CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia

Pharmacogenomic (PGx) testing to inform antidepressant medication selection and dosing is gaining attention from healthcare professionals, patients, and payors in Australia. However, there is often uncertainty regarding which test is most suitable for a particular patient. Here, we identified and ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Forbes, Malcolm, Hopwood, Mal, Bousman, Chad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606650/
https://www.ncbi.nlm.nih.gov/pubmed/37895294
http://dx.doi.org/10.3390/genes14101945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606650/
https://www.ncbi.nlm.nih.gov/pubmed/37895294
http://dx.doi.org/10.3390/genes14101945

Ejemplares similares